Therefore, the debatable potential of hormone therapy in HCC may finally be attributed to the lack of complete understanding of ER and AR expression and hormonal responsiveness in the liver and their involvement in development of HCC [106]. The gene discussed is ESR1; the disease is hepatocellular carcinoma.